[News] Prof. Jae Min Cha’s Research Team Selected for MSIT’s ‘Bio & Medical Technology Development Program,’ Launching Global Research Network

The research team with Professor Jae Min Cha has been officially selected for the "Global Research Network for Multilayered Stroke Treatment Technology through the Convergence of Electroceuticals and Advanced Bio-Nanomaterials" project. This initiative is supported by the Ministry of Science and ICT (MSIT) and the National Research Foundation of Korea (NRF).

- Project Title: Global Research Network for Multilayered Stroke Treatment Technology through the Convergence of Electroceuticals and Advanced Bio-Nanomaterials

- Research Goal: Innovative Fusion of Electroceuticals and Bio-Nanomaterials

- Period: Jan 1, 2026 – Dec 31, 2027 (2 years)

- Supporting Agency: Ministry of Science and ICT (MSIT), National Research Foundation of Korea (NRF)

- Program: Bio & Medical Technology Development Program (Infrastructure for Bio-Innovation)

Strong Partnerships with Leading Global Institutions

This project is being conducted through intensive technical and personnel exchanges with world-renowned research institutions. Notably, Professor Jae Min Cha is currently conducting a Sabbatical Year at the University of Sydney Pharmacy School until Feb. 2027, where he is leading active collaborative research with Professor Wojciech Chrzanowski, a global authority in nanobio-characterization and extracellular vesicles.

- University of Sydney (Australia): Nano-bio characterization of exosomes and verification of neuroregenerative efficacy.

- Johns Hopkins University (USA): Establishing administration strategies using Prof. Deok-Ho Kim’s iPSC-based Blood-Brain Barrier (BBB) organoid models.

- A*STAR (Singapore): Developing hybrid therapeutics and mass-producing high-purity iPSC-derived mitochondria with Dr. Boon Seng Soh.

Empowering Promising Researchers & Future Outlook

Our lab is committed to fostering the global expertise of our researchers through verified partnerships and a shared scientific vision.

- Global Dispatch Program: Promising researchers, including Mingyu Jeon, So Young An, and Wu Young Kang, will be dispatched to The University of Sydney, Johns Hopkins University and A*STAR laboratories. They will acquire advanced technical knowledge on-site, conduct core experiments, and lead the publication of joint international research papers.

- Paving the Way for Commercialization: By establishing global standardized production SOPs and QC/QA criteria, we will lay the foundation for translating our lab’s original technologies into real-world clinical practice.

The 3D Stem Cell Bioengineering Lab at Incheon National University will continue to bridge global research frontiers, striving to become a global hub that provides innovative therapeutic alternatives for stroke patients worldwide.